- On Announcement of All Oral MDR TB regimen by Indian Government
- Modi visit to US: Trump appearance signals importance of India
- After ‘Howdy Modi’, Trump and Modi likely to sign trade deal
- US – India Relations: President Trump To Sign New Trade Deal With Indian PM Modi?
- India-US trade talks: Trading lives?
Category Archives: Patent Opposition
People living with hepatitis C and HIV challenge evergreening patents on lifesaving hepatitis C drugs in India
New Delhi, 10 July 2018: Delhi Network of Positive People (DNP+) has filed today two patent oppositions before the Indian patent office, challenging additional patent claims by US pharmaceutical corporation-Gilead Sciences for the hepatitis C medicines sofosbuvir and velpatasvir. These … Continue reading
by Tahir Amin, CNBC | June 27, 2018 One in four Americans are unable to fill prescriptions due to high prices. Today’s drug patent monopolies are stronger than at any point in the last century, raising prescription prices. Until the … Continue reading
Source: Fix the Patent Laws Intellectual property policy welcomed after nine years of development JOHANNESBURG, 31 MAY 2018 – Yesterday, after nine years of development, the Department of Trade and Industry (the dti) finally published the Intellectual Property Policy of the … Continue reading
Doctors Without Borders urges Pfizer to drop unmerited patents that hinder access to lifesaving childhood vaccine worldwide NEW YORK/SEOUL, FEBRUARY 6, 2018—The international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) is in the process of submitting a legal … Continue reading
MSF’s unprecedented legal challenge of the patent on Pfizer’s pneumonia vaccine Prevenar 13 in India is a “rational … coherent” strategy which, if successful, could save lives by opening the way for cheaper vaccines, a WHO vaccine expert tells Development Today. The … Continue reading
Pfizer has come under fire for holding exclusive patent rights that bars competition on its pneumonia vaccine worldwide, which is being challenged in patent litigations in several countries, an aid group said Monday. Doctors Without Borders will challenge Pfizer in … Continue reading